CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Clinical trials for CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA) explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA) trials appear
Sign up with your email to follow new studies for CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone drug tested as new hope for rare blood disorder
Disease control Recruiting nowThis early-stage study is testing whether a medication called Zoledronic acid, usually used for bone health, can help adults with a rare inherited blood disorder called Congenital Dyserythropoietic Anemia (CDA). The main goal is to see if the treatment can safely increase patient…
Matched conditions: CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New test could predict severity of sickle cell and rare anemias
Knowledge-focused Recruiting nowThis study aims to develop better tools to understand and predict the course of rare inherited blood disorders like sickle cell disease. Researchers will combine detailed blood cell analysis, genetic testing, and patient health information to create personalized profiles for 200 …
Matched conditions: CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC